Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics

被引：0
|
作者：
Karagianis, JL [1 ]
Dunayevich, E
机构：
[1] Eli Lilly Canada Inc, Scarborough, ON, Canada
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2005年 / 66卷 / 01期
关键词：
D O I：
10.4088/JCP.v66n0118f
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics
    Alméras, N
    Després, JP
    Villeneuve, J
    Demers, MF
    Roy, MA
    Cadrin, C
    Mottard, JP
    Bouchard, RH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 557 - 564
  • [2] Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics -: Dr. Almeras and colleagues reply
    Alméras, N
    Després, JP
    Villeneuve, J
    Demers, MF
    Bouchard, RH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 138 - 138
  • [3] Development of an atherogenic metabolic risk profile associated with the use of some atypical neuroleptics.
    Alméras, N
    Villeneuve, J
    Demers, MF
    Cadrin, C
    Mottard, JP
    Bouchard, RH
    Després, JP
    [J]. OBESITY RESEARCH, 2001, 9 : 161S - 161S
  • [4] Metabolic Disturbances Associated with the Use of the Atypical Antipsychotics
    Thomas, Barbara
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 : 22 - 22
  • [5] Atherogenic metabolic risk profile observed among schizophrenic patients treated with atypical antipsychotics: Contribution of body fat distribution
    Blouin, M
    Roy, MA
    Bouchard, RH
    Despres, JP
    Almeras, N
    [J]. OBESITY RESEARCH, 2005, 13 : A183 - A183
  • [6] Metabolic Effects Associated to Atypical Antipsychotics
    Amboage Paz, M. T.
    Diaz Peromingo, J. A.
    [J]. NORTE DE SALUD MENTAL, 2008, 7 (32): : 37 - 40
  • [7] Features of the metabolic syndrome associated with the use of atypical antipsychotics: Is there a role for adiponectin?
    Almeras, N
    Bouchard, RH
    Demers, MF
    Villeneuve, J
    Roy, MA
    Despres, JP
    [J]. OBESITY RESEARCH, 2004, 12 : A130 - A130
  • [8] Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre
    Tarricone, Ilaria
    Casoria, Michela
    Gozzi, Beatrice Ferrari
    Grieco, Daniela
    Menchetti, Marco
    Serretti, Alessandro
    Ujkaj, Manjola
    Pastorelli, Francesca
    Berardi, Domenico
    [J]. BMC PSYCHIATRY, 2006, 6 (1)
  • [9] Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre
    Ilaria Tarricone
    Michela Casoria
    Beatrice Ferrari Gozzi
    Daniela Grieco
    Marco Menchetti
    Alessandro Serretti
    Manjola Ujkaj
    Francesca Pastorelli
    Domenico Berardi
    [J]. BMC Psychiatry, 6
  • [10] Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
    Hasnain, Mehrul
    Fredrickson, Sonja K.
    Vieweg, W. Victor R.
    Pandurangi, Anand K.
    [J]. CURRENT DIABETES REPORTS, 2010, 10 (03) : 209 - 216
12345